Senior Biotech Executive with 30+ years of experience in big pharma and small biotech companies, public and private. Raised over $80MM of capital, executed 50+ partnerships/strategic alliances with valuations up to $1.5B. Founded a Fractional Executive consulting firm focused on early stage biotechs. Therapeutic Specialties include biologics, cell therapy, autoimmune/rheumatology, oncology, rare/orphan disease, dermatology, CNS and ophthalmology. C-suite experience as CEO and CBO driving drug development and corporate strategy with proven track record of achieving partnerships and funding.